Biologic Drugs With Established Pharmaceutical Class: Vascular Endothelial Growth Factor Receptor 2 Antagonist
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: Vascular Endothelial Growth Factor Receptor 2 Antagonist
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | CYRAMZA | ramucirumab | Injection | 125477 | 2014-04-21 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |